PremiumRatingsSell Rating Reiterated for Ginkgo Bioworks Holdings Amid Revenue Visibility and Growth Concerns Largest borrow rate increases among liquid names Twist Bioscience, Ginkgo Bioworks revise collaboration agreement PremiumThe FlyGinkgo Bioworks reports Q1 EPS ($1.68) vs ($3.32) last year Ginkgo Bioworks raises FY25 revenue view to $167M-$187M, consensus $173.04M Ginkgo Bioworks options imply 12.9% move in share price post-earnings PremiumThe FlyGinkgo Bioworks falls -4.8% Largest borrow rate increases among liquid names Ginkgo Bioworks Holdings: Balancing Growth and Uncertainty with a Hold Rating 
